CCL5 and hepatocellular carcinoma: Specifically, fecal levels of calprotectin, a marker of local inflammation released by intestinal neutrophils, were elevated in the HCC group together with plasma levels of proinflammatory chemokines (IL-8, IL-13, CCL3, CCL4, and CCL5) compared to cirrhotic patients without HCC.